| Title |
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
|
|---|---|
| Published in |
Annals of Clinical Microbiology and Antimicrobials, May 2020
|
| DOI | 10.1186/s12941-020-00368-w |
| Pubmed ID | |
| Authors |
Khan Sharun, Kuldeep Dhama, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Bhoj Raj Singh, Ranjit Sah, D. Katterine Bonilla-Aldana, Alfonso J. Rodriguez-Morales, Hakan Leblebicioglu |
X Demographics
The data shown below were collected from the profiles of 326 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 45 | 14% |
| Mexico | 17 | 5% |
| Venezuela, Bolivarian Republic of | 9 | 3% |
| India | 8 | 2% |
| Colombia | 8 | 2% |
| United Kingdom | 6 | 2% |
| Canada | 6 | 2% |
| Chile | 5 | 2% |
| Peru | 4 | 1% |
| Other | 34 | 10% |
| Unknown | 184 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 285 | 87% |
| Practitioners (doctors, other healthcare professionals) | 18 | 6% |
| Scientists | 16 | 5% |
| Science communicators (journalists, bloggers, editors) | 5 | 2% |
| Unknown | 2 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 374 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 374 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 54 | 14% |
| Researcher | 31 | 8% |
| Student > Master | 30 | 8% |
| Other | 26 | 7% |
| Student > Doctoral Student | 22 | 6% |
| Other | 87 | 23% |
| Unknown | 124 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 80 | 21% |
| Pharmacology, Toxicology and Pharmaceutical Science | 37 | 10% |
| Biochemistry, Genetics and Molecular Biology | 24 | 6% |
| Chemistry | 13 | 3% |
| Immunology and Microbiology | 10 | 3% |
| Other | 66 | 18% |
| Unknown | 144 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 270. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2023.
All research outputs
#136,322
of 25,761,363 outputs
Outputs from Annals of Clinical Microbiology and Antimicrobials
#2
of 682 outputs
Outputs of similar age
#4,870
of 433,644 outputs
Outputs of similar age from Annals of Clinical Microbiology and Antimicrobials
#1
of 13 outputs
Altmetric has tracked 25,761,363 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 682 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,644 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.